Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.
EFTEMLY
Show more
Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, infection and inflammatory diseases and disorders
Class 5 – Pharmaceuticals & supplements
Status timeline
- 27 Jun 2020Application filedNew Application Entered
- 4 Sep 2020Assigned to an examining attorneyAssigned To Examiner
- 10 Sep 2020Office action issuedNon-Final Action Written
- 25 Feb 2021Response to office action filedTeas Response To Office Action Received
- 27 May 2021Approved for publicationApproved For Pub - Principal Register
- 6 Jul 2021Published for oppositionPublished For Opposition
- 31 Aug 2021Notice of allowance issued — statement of use requiredNoa Mailed - Sou Required From Applicant
- 22 Mar 2022Registered on the Principal RegisterRegistered-Principal Register
All 24 events
| 2022-03-22 | Registered-Principal Register |
| 2022-02-11 | Case Assigned To Intent To Use Paralegal |
| 2022-02-11 | 1(B) Basis Deleted; Proceed To Registration |
| 2022-01-18 | Teas Delete 1(B) Basis Received |
| 2022-01-18 | Notice Of Allowance Cancelled |
| 2021-08-31 | Noa Mailed - Sou Required From Applicant |
| 2021-07-22 | Teas Revoke/App/Change Addr Of Atty/Dom Rep Received |
| 2021-07-22 | Attorney/Dom.rep.revoked And/Or Appointed |
| 2021-07-22 | Teas Change Of Domestic Representatives Address |
| 2021-07-22 | Teas Change Of Correspondence Received |
| 2021-07-06 | Published For Opposition |
| 2021-07-06 | Official Gazette Publication Confirmation E-Mailed |
| 2021-06-16 | Notification Of Notice Of Publication E-Mailed |
| 2021-05-27 | Correspondence Received In Law Office |
| 2021-05-27 | Teas/Email Correspondence Entered |
| 2021-05-27 | Approved For Pub - Principal Register |
| 2021-05-26 | Assigned To Lie |
| 2021-02-25 | Teas Response To Office Action Received |
| 2020-09-10 | Non-Final Action Written |
| 2020-09-10 | Non-Final Action E-Mailed |
| 2020-09-10 | Notification Of Non-Final Action E-Mailed |
| 2020-09-04 | Assigned To Examiner |
| 2020-07-21 | New Application Office Supplied Data Entered |
| 2020-06-27 | New Application Entered |
Goods & services by class
Class 5 Pharmaceuticals & supplements
Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, infection and inflammatory diseases and disorders
Owner details
See the official record for contact details. View official record →
Source & freshness
Source: the official United States trademark register. This record was last updated on 22 Mar 2022; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.